Mehmet Sofuoglu1, Ellen Mitchell, Marc Mooney. 1. Department of Psychiatry and VA Connecticut Healthcare System, Yale University School of Medicine, West Haven, Connecticut 06516, USA. Mehmet.Sofuoglu@yale.edu
Abstract
OBJECTIVE: Previous studies suggest possible modulatory effects of progesterone on nicotine addiction. The goal of this study was to determine the effects of progesterone, on acute physiological and subjective responses to intravenous (IV) nicotine in overnight abstinent male and female smokers. METHODS:Twelve smokers, six males and six females, participated in a double-blind, placebo-controlled, crossover study, which consisted of two experimental sessions. Before each session, subjects were treated orally with a single dose of either 200 mg progesterone or placebo. Starting 2 h following the medication treatment, subjects received an IV saline injection, followed by 0.5 and 1.0 mg/70 kg IV nicotine. RESULTS: Progesterone treatment, compared to placebo, enhanced the ratings of "bad effects," from IV nicotine and attenuated the rating of "drug liking." Progesterone also enhanced suppression of smoking urges by nicotine as assessed by the Brief Questionnaire on Smoking Urges (BQSU). CONCLUSIONS: These results suggest that progesterone may alter the subjective effects of nicotine as well as urges to smoke cigarettes. Further studies are warranted to examine the modulation of nicotine's effects by gonadal hormones.
RCT Entities:
OBJECTIVE: Previous studies suggest possible modulatory effects of progesterone on nicotine addiction. The goal of this study was to determine the effects of progesterone, on acute physiological and subjective responses to intravenous (IV) nicotine in overnight abstinent male and female smokers. METHODS: Twelve smokers, six males and six females, participated in a double-blind, placebo-controlled, crossover study, which consisted of two experimental sessions. Before each session, subjects were treated orally with a single dose of either 200 mg progesterone or placebo. Starting 2 h following the medication treatment, subjects received an IV saline injection, followed by 0.5 and 1.0 mg/70 kg IV nicotine. RESULTS:Progesterone treatment, compared to placebo, enhanced the ratings of "bad effects," from IV nicotine and attenuated the rating of "drug liking." Progesterone also enhanced suppression of smoking urges by nicotine as assessed by the Brief Questionnaire on Smoking Urges (BQSU). CONCLUSIONS: These results suggest that progesterone may alter the subjective effects of nicotine as well as urges to smoke cigarettes. Further studies are warranted to examine the modulation of nicotine's effects by gonadal hormones.
Authors: J A Simon; D E Robinson; M C Andrews; J R Hildebrand; M L Rocci; R E Blake; G D Hodgen Journal: Fertil Steril Date: 1993-07 Impact factor: 7.329
Authors: Kelly P Cosgrove; Irina Esterlis; Sherry A McKee; Frederic Bois; John P Seibyl; Carolyn M Mazure; Suchitra Krishnan-Sarin; Julie K Staley; Marina R Picciotto; Stephanie S O'Malley Journal: Arch Gen Psychiatry Date: 2012-04
Authors: Angela M Lee; Cali A Calarco; Sherry A McKee; Yann S Mineur; Marina R Picciotto Journal: Genes Brain Behav Date: 2019-08-13 Impact factor: 3.449
Authors: Elizabeth E Van Voorhees; John T Mitchell; F Joseph McClernon; Jean C Beckham; Scott H Kollins Journal: Med Hypotheses Date: 2012-02-15 Impact factor: 1.538
Authors: Michael E Saladin; Erin A McClure; Nathaniel L Baker; Matthew J Carpenter; Viswanathan Ramakrishnan; Karen J Hartwell; Kevin M Gray Journal: Nicotine Tob Res Date: 2015-04 Impact factor: 4.244
Authors: Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee Journal: Nicotine Tob Res Date: 2015-04 Impact factor: 4.244